Hypoxemia Related to COVID-19 May Benefit From Almitrine Treatment
In patients with acute respiratory distress syndrome related to SARS-CoV-2, treatment with almitrine was shown to be associated with an increased PaO2/FiO2 ratio.
Sheila Jacobs
Contributing Writer https://www.infectiousdiseaseadvisor.com
Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, promotional, and managed care arenas, from the conceptual stage through completion of the final editorial product. Her focus has been in a diverse array of therapeutic areas.
